NCT01066728View on ClinicalTrials.gov

CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

September 30, 2005

Study Completion Date

March 31, 2007

Conditions
Apnea of Prematurity
Interventions
OTHER

CO2 inhalation

Inhalation of CO2 (3% at the source, approximately 1% inhaled) with room air by nasal prongs at 0.5 l/min for 3 days

DRUG

Theophylline

Trial Locations (2)

R2H 2A6

St Boniface General Hospital, Winnipeg

R3E 0L8

Health Sciences Centre, Winnipeg

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

The Children's Hospital Foundation of Manitoba

UNKNOWN

lead

University of Manitoba

OTHER

NCT01066728 - CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity | Biotech Hunter | Biotech Hunter